Products for Research Use Only

Cannabidiorcol

CAT: 0804-HY-121841Size: 1 mg (38.70 mM x 100 μL in Acetonitrile)Dry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-121841Size:1 mg (38.70 mM x 100 μL in Acetonitrile)
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cannabidiorcol (CBDO, CBD-C1, O-1821) is related to cannabidiol, with the pentyl side chain shortened to a methyl group. Cannabidiorcol has low affinity for cannabinoid receptors (CBs) and is an agonist of the transient receptor potential channel (TRP channel), through which it produces antiinflammatory effects, but can also promote tumorigenesis at high concentrations[1][2].
CAS Number
35482-50-9
Product Name Alternative
O-1821; CBD-C1
UNSPSC
12352005
Hazard Statement
H225, H302+H312+H332, H319
Target
TRP Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cannabidiorcol.html
Concentration
38.70 mM * 100 μL in Acetonitrile
Purity
99.0
Solubility
10 mM in DMSO
Smiles
OC1=C([C@H]2[C@@H](CCC(C)=C2)C(C)=C)C(O)=CC(C)=C1
Molecular Formula
C17H22O2
Molecular Weight
258.36
Precautions
H225, H302+H312+H332, H319
References & Citations
[1]Teresina Laragione, et al. Combination therapy of a TRPV2 agonist with a TNF inhibitor achieves sustained suppression of disease severity and reduced joint damage. Clin Exp Immunol. 2023 Mar; 211 (3) : 233–238.|[2]Rongqi Huang, et al. Thermal stress involved in TRPV2 promotes tumorigenesis through the pathways of HSP70/27 and PI3K/Akt/mTOR in esophageal squamous cell carcinoma. Br J Cancer. 2022 Nov 1; 127 (8) : 1424–1439.
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AChE

Related Products